X-Gen Pharmaceuticals Inc. FDA Recalls

3 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product	Reason	Class	Initiated
Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, AClass IIIApr 2, 2024Labeling: Incorrect or missing Package Insert: There is an e	Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Prep	Class IIIDrugs	Apr 2, 2024
Cyclophosphamide for Injection, USP, 500mg/vial, Lyophilized, Cytotoxic Agent, Single Dose Vial for Intravenous Use, Rx Class IIIApr 2, 2024Labeling: Incorrect or missing Package Insert: There is an e	Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Prep	Class IIIDrugs	Apr 2, 2024
Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets, Manufactured for: X-GEN Phamaceuticals, Inc.Class IIMar 19, 2021Failed Stability Specifications: Out of Specification (OOS)	Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay	Class IIDrugs	Mar 19, 2021